Compare IRM & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRM | NTRA |
|---|---|---|
| Founded | 1951 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0B | 28.2B |
| IPO Year | 1997 | 2015 |
| Metric | IRM | NTRA |
|---|---|---|
| Price | $126.31 | $202.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 15 |
| Target Price | $122.50 | ★ $259.07 |
| AVG Volume (30 Days) | ★ 1.5M | 1.5M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 0.65 |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $4,491,531,000.00 | $210,939,000.00 |
| Revenue This Year | $13.30 | $18.08 |
| Revenue Next Year | $9.31 | $19.65 |
| P/E Ratio | $264.17 | ★ N/A |
| Revenue Growth | ★ 8.30 | N/A |
| 52 Week Low | $77.77 | $131.81 |
| 52 Week High | $134.09 | $256.36 |
| Indicator | IRM | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 58.26 | 50.89 |
| Support Level | $98.60 | $186.96 |
| Resistance Level | $134.09 | $204.34 |
| Average True Range (ATR) | 3.26 | 10.78 |
| MACD | -0.78 | 0.10 |
| Stochastic Oscillator | 36.54 | 49.78 |
Iron Mountain Inc is an information management services provider organized and operated as a real estate investment trust. The company offers solutions to its clients to address their information management, digital transformation, information security, data center, and asset lifecycle management (ALM) needs. Its customers come from various industries, including commercial, legal, financial, healthcare, technology, etc. The company has two reportable segments: Global Records and Information Management (Global RIM) and Global Data Center. Maximum revenue is generated from the Global RIM segment, which offers data and records management, secure shredding, consumer storage, and other related services. Geographically, the company generates maximum revenue from the United States.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.